In a research report sent to investors today, MLV analyst George Zavoico maintained a Buy rating on Pluristem Therapeutics (NASDAQ:PSTI) with a $6.00 …
MLV analyst George Zavoico was out pounding the table on Omeros (NASDAQ:OMER) Wednesday, reiterating a Buy rating and a price target of $38.00, which implies …
In a research report sent to investors today, MLV analyst George Zavoico reiterated a Buy rating on Cytokinetics, Inc. (NASDAQ:CYTK) with a $9.
In a research report released Friday, MLV analyst George Zavoico reiterated a Buy rating on Agenus (NASDAQ:AGEN) and raised his price target to $9.00 …
In a research report issued today, MLV analyst George Zavoico maintained a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) and raised his price target …
In a research report released today, MLV analyst George Zavoico reiterated a Buy rating on Cerus (NASDAQ:CERS) with a price target of $10, …
Just two days after approving Cerus’ (NASDAQ:CERS) INTERCEPT Blood System for Plasma, the FDA comes through and approves INTERCEPT Blood System for Platelets. …
In a research report sent to investors today, MLV analyst George Zavoico reiterated a Buy rating on Agenus (NASDAQ:AGEN) with a $6.00 price …
In a research report issued today, MLV analyst George Zavoico reiterated a Buy rating on Threshold Pharmaceuticals (NASDAQ:THLD) with a $14.50 price target, …
MLV analyst George Zavoico is out again today with a new research note on Cerus (NASDAQ:CERS), raising his price target to $10 (from $7), while maintaining a …